{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:16:59Z","timestamp":1793891819554,"version":"4.8.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571787"],"award-info":[{"award-number":["81571787"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32101094"],"award-info":[{"award-number":["32101094"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.biopha.2024.117371","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T19:22:20Z","timestamp":1725045740000},"page":"117371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Targeted counteracting of overactive macrophages by melittin stable-loaded solid lipid nanoparticles alleviates cytokine storm and acute inflammatory injury"],"prefix":"10.1016","volume":"179","author":[{"given":"Yuan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningshuang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanyuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6510-325X","authenticated-orcid":false,"given":"Samuel","family":"Kesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2578-4863","authenticated-orcid":false,"given":"Xiaohui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1655-8389","authenticated-orcid":false,"given":"Jinliang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.117371_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.virol.2015.02.051","article-title":"PRRs are watching you: localization of innate sensing and signaling regulators","volume":"479-480","author":"Chow","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.biopha.2024.117371_bib2","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine Storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2024.117371_bib3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.it.2021.06.001","article-title":"The 'cytokine storm': molecular mechanisms and therapeutic prospects","volume":"42","author":"Karki","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biopha.2024.117371_bib4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.biopha.2024.117371_bib5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41591-018-0068-9","article-title":"Modeling cytokine release syndrome","volume":"24","author":"Rooney","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2024.117371_bib6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41591-018-0041-7","article-title":"CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade","volume":"24","author":"Giavridis","year":"2018","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2024.117371_bib7","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41591-018-0036-4","article-title":"Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells","volume":"24","author":"Norelli","year":"2018","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2024.117371_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173556","article-title":"Corticosteroid therapy is associated with the delay of SARS-CoV-2 clearance in COVID-19 patients","volume":"889","author":"Huang","year":"2020","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2024.117371_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13412","article-title":"The role of methylprednisolone on preventing disease progression for hospitalized patients with severe COVID-19","volume":"50","author":"Yang","year":"2020","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.biopha.2024.117371_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.570993","article-title":"Controlling Cytokine Storm Is Vital in COVID-19","volume":"11","author":"Tang","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2024.117371_bib11","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.7150\/thno.47982","article-title":"Nanomedicine therapies modulating Macrophage Dysfunction: a potential strategy to attenuate Cytokine Storms in severe infections","volume":"10","author":"Liu","year":"2020","journal-title":"Theranostics"},{"issue":"Suppl 2","key":"10.1016\/j.biopha.2024.117371_bib12","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar1916","article-title":"Interleukin-6: discovery of a pleiotropic cytokine","volume":"8","author":"Kishimoto","year":"2006","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.biopha.2024.117371_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S2213-2600(21)00103-X","article-title":"Interleukin-6: obstacles to targeting a complex cytokine in critical illness","volume":"9","author":"McElvaney","year":"2021","journal-title":"Lancet Respir. Med"},{"key":"10.1016\/j.biopha.2024.117371_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114769","article-title":"Applications and evolution of melittin, the quintessential membrane active peptide","volume":"193","author":"Guha","year":"2021","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2024.117371_bib15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jconrel.2021.07.005","article-title":"Polymeric microneedle-mediated transdermal delivery of melittin for rheumatoid arthritis treatment","volume":"336","author":"Du","year":"2021","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2024.117371_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21050616","article-title":"Anti-Inflammatory Applications of Melittin, a Major Component of Bee Venom: Detailed Mechanism of Action and Adverse Effects","volume":"21","author":"Lee","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.117371_bib17","first-page":"1270","article-title":"Research progress in the treatment of inflammatory diseases with melittin","volume":"40","author":"Zhou","year":"2023","journal-title":"Chin. J. Mod. Appl. Pharm."},{"key":"10.1016\/j.biopha.2024.117371_bib18","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1002\/art.20626","article-title":"Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit","volume":"50","author":"Park","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2024.117371_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bcp.2006.09.023","article-title":"Melittin inhibits inflammatory target gene expression and mediator generation via interaction with IkappaB kinase","volume":"73","author":"Park","year":"2007","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2024.117371_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-9255-5-7","article-title":"JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin","volume":"5","author":"Park","year":"2008","journal-title":"J. Inflamm. (Lond. )"},{"key":"10.1016\/j.biopha.2024.117371_bib21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejphar.2014.06.058","article-title":"Protective effect of melittin against inflammation and apoptosis on Propionibacterium acnes-induced human THP-1 monocytic cell","volume":"740","author":"Lee","year":"2014","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2024.117371_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.canlet.2017.05.010","article-title":"Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy","volume":"402","author":"Rady","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2024.117371_bib23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40360-021-00503-z","article-title":"In vitro and in vivo toxicity and antibacterial efficacy of melittin against clinical extensively drug-resistant bacteria","volume":"22","author":"Askari","year":"2021","journal-title":"BMC Pharm. Toxicol."},{"key":"10.1016\/j.biopha.2024.117371_bib24","article-title":"Melittin-based nano-delivery systems for cancer therapy","volume":"12","author":"Wang","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2024.117371_bib25","doi-asserted-by":"crossref","first-page":"17158","DOI":"10.1021\/acsami.1c03640","article-title":"Delivery Strategies for Melittin-Based Cancer Therapy","volume":"13","author":"Zhou","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2024.117371_bib26","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s41467-020-14906-9","article-title":"Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response","volume":"11","author":"Yu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.117371_bib27","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1021\/nn400683s","article-title":"Hybrid melittin cytolytic Peptide-driven ultrasmall lipid nanoparticles block melanoma growth in vivo","volume":"7","author":"Huang","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2024.117371_bib28","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1039\/C5NR05577F","article-title":"RGD-modified lipid disks as drug carriers for tumor targeted drug delivery","volume":"8","author":"Gao","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2024.117371_bib29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jconrel.2011.08.029","article-title":"PEG-stabilized lipid disks as carriers for amphiphilic antimicrobial peptides","volume":"156","author":"Zetterberg","year":"2011","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2024.117371_bib30","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jconrel.2023.12.013","article-title":"Glutamate affects self-assembly, protein corona, and anti-4 T1 tumor effects of melittin\/vitamin E-succinic acid-(glutamate)n nanoparticles","volume":"365","author":"Jin","year":"2023","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2024.117371_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12645-022-00154-7","article-title":"A simple self-assembling system of melittin for hepatoma treatment","volume":"14","author":"Jin","year":"2023","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/j.biopha.2024.117371_bib32","doi-asserted-by":"crossref","first-page":"55902","DOI":"10.1021\/acsami.1c17618","article-title":"Stable loading and delivery of melittin with lipid-coated polymeric nanoparticles for effective tumor therapy with negligible systemic toxicity","volume":"13","author":"Ye","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2024.117371_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/727241","article-title":"Targeted liposomal drug delivery to monocytes and macrophages","volume":"2011","author":"Kelly","year":"2011","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.biopha.2024.117371_bib34","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.addr.2004.01.012","article-title":"Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis","volume":"56","author":"Paulos","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2024.117371_bib35","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1182\/blood-2008-04-150789","article-title":"A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages","volume":"113","author":"Xia","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2024.117371_bib36","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.nano.2018.01.009","article-title":"Selective liposome targeting of folate receptor positive immune cells in inflammatory diseases","volume":"14","author":"Poh","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2024.117371_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201606628","article-title":"Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization","volume":"29","author":"Sun","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2024.117371_bib38","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.addr.2012.03.006","article-title":"Development of macromolecular prodrug for rheumatoid arthritis","volume":"64","author":"Yuan","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2024.117371_bib39","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.33549\/physiolres.933977","article-title":"Polymer-drug conjugates in inflammation treatment","volume":"67","author":"Koziolova","year":"2018","journal-title":"Physiol. Res"},{"key":"10.1016\/j.biopha.2024.117371_bib40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fimmu.2020.00218","article-title":"Targeting of Hepatic Macrophages by Therapeutic Nanoparticles","volume":"11","author":"Colino","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2024.117371_bib41","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/1529-0131(199908)42:8<1609::AID-ANR7>3.0.CO;2-L","article-title":"Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis","volume":"42","author":"Nakashima-Matsushita","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2024.117371_bib42","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.117371_bib43","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13914","article-title":"Jr., LPS-stimulated NF-kappaB p65 dynamic response marks the initiation of TNF expression and transition to IL-10 expression in RAW 264.7 macrophages","volume":"6","author":"Hobbs","year":"2018","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.biopha.2024.117371_bib44","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41401-020-00597-x","article-title":"Deletion of TLR4 attenuates lipopolysaccharide-induced acute liver injury by inhibiting inflammation and apoptosis","volume":"42","author":"Chen","year":"2021","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2024.117371_bib45","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1586\/ers.10.71","article-title":"The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine","volume":"4","author":"Chen","year":"2010","journal-title":"Expert Rev. Respir. Med"},{"key":"10.1016\/j.biopha.2024.117371_bib46","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2024.117371_bib47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s41232-020-00131-w","article-title":"Macrophage activation syndrome and COVID-19","volume":"40","author":"Otsuka","year":"2020","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.biopha.2024.117371_bib48","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2016.12.032","article-title":"Nanomedicines for dysfunctional macrophage-associated diseases","volume":"247","author":"He","year":"2017","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2024.117371_bib49","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41401-020-00516-0","article-title":"Melittin ameliorates inflammation in mouse acute liver failure via inhibition of PKM2-mediated Warburg effect","volume":"42","author":"Fan","year":"2021","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2024.117371_bib50","first-page":"137","article-title":"Evaluation and Analysis of LPS Induced Acute Lung Injury in Mouse","volume":"14","author":"Wen","year":"2017","journal-title":"Med. Innov. China"},{"key":"10.1016\/j.biopha.2024.117371_bib51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/path.1491","article-title":"Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome","volume":"202","author":"Bhatia","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.biopha.2024.117371_bib52","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/26239","article-title":"Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling","volume":"395","author":"Yang","year":"1998","journal-title":"Nature"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224012563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224012563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:03:22Z","timestamp":1784761402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224012563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":52,"alternative-id":["S0753332224012563"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117371","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted counteracting of overactive macrophages by melittin stable-loaded solid lipid nanoparticles alleviates cytokine storm and acute inflammatory injury","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117371","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117371"}}